e-learning
resources
Virtual 2021
05.09.2021
News in treatment and diagnosis of idiopathic interstitial pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Post-hoc analysis of DWN12088: Comparative analysis between fasting period and adverse event incidences in Healthy subjects
M. Park (Seoul, Republic of Korea), J. Heo (Seoul, Republic of Korea), Y. Kim (Seoul, Republic of Korea), J. Han (Seoul, Republic of Korea)
Source:
Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia
Session:
News in treatment and diagnosis of idiopathic interstitial pneumonia
Session type:
E-poster
Number:
470
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Park (Seoul, Republic of Korea), J. Heo (Seoul, Republic of Korea), Y. Kim (Seoul, Republic of Korea), J. Han (Seoul, Republic of Korea). Post-hoc analysis of DWN12088: Comparative analysis between fasting period and adverse event incidences in Healthy subjects. 470
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Predictors of loss of asthma control in the Phase 2a INCONTRO trial: A post-hoc analysis
Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights
Year: 2020
Efficacy of aclidinium/formoterol: pooled post hoc analysis of patients naïve to COPD maintenance therapy
Source: International Congress 2017 – COPD management
Year: 2017
Treatment response in COPD: does FEV
1
say it all? A
post hoc
analysis of the CRYSTAL study
Source: ERJ Open Res, 5 (1) 00243-2018; 10.1183/23120541.00243-2018
Year: 2019
Impact of grouping patients by 2017 GOLD strategy assessment criteria: a post hoc analysis of the TONADO and OTEMTO trials
Source: International Congress 2017 – COPD management: new findings from large studies
Year: 2017
Cluster analysis identifying patients with COPD at high-risk of 2-year mortality: preliminary results.
Source: International Congress 2017 – Assessing the functional status of patients with COPD
Year: 2017
Post-hoc analysis of the effect of montelukast in treating post-RSV-bronchiolitic respiratory symptoms in children
Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma
Year: 2007
Late-breaking abstract: Comparative analysis of cardiopulmonary and clinical responses to six minute walking test and maximal exercising test in obese women
Source: Annual Congress 2011 - Physiological basis of respiratory disease
Year: 2011
Mometasone/ indacaterol/ glycopyrronium demonstrates similar efficacy in men and women: post hoc analysis of IRIDIUM study
Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence
Year: 2021
Nintedanib in IPF: post hoc analysis of the Italian FIBRONET observational study
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020
Improvements in lung function with umeclidinium/vilanterol analysed by reversibility at screening: a post hoc analysis of the EMAX trial
Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies
Year: 2021
ICS withdrawal and exacerbation risk by GOLD 2017 Report: post hoc analysis of the WISDOM trial
Source: International Congress 2018 – Primary care management of respiratory conditions
Year: 2018
Correlation between clinic and remote FEV1 and FeNO measurements; post hoc analysis of the INCONTRO study
Source: Virtual Congress 2020 – Exhaled biomarkers of asthma and the asthma burden
Year: 2020
Post hoc
analysis of a randomised controlled trial: effect of vitamin D supplementation on circulating levels of desmosine in COPD
Source: ERJ Open Res, 6 (4) 00128-2019; 10.1183/23120541.00128-2019
Year: 2020
Multivariate cluster analysis of immunopathological and clinical data from the U-BIOPRED severe asthma study: Preliminary results
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
Impact of turnaround time on outcome with point-of-care testing for respiratory viruses: a
post hoc
analysis from a randomised controlled trial
Source: Eur Respir J, 52 (2) 1800555; 10.1183/13993003.00555-2018
Year: 2018
Relationship between baseline rescue medication use and reductions in COPD exacerbation rates: a subgroup analysis of the ETHOS trial
Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies
Year: 2021
Late Breaking Abstract - Risk of a severe exacerbation following higher reliever use: post-hoc analysis of SYGMA 1 in mild asthma
Source: International Congress 2018 – Variant forms of asthma
Year: 2018
Statistical analysis of exacerbation rates in COPD: TRISTAN and ISOLDE revisited
Source: Eur Respir J 2008; 32: 17-24
Year: 2008
Statistical cluster analysis on the BTS refractory asthma cohort
Source: Annual Congress 2011 - Respiratory epidemiology: methods, definitions and phenotypes
Year: 2011
Interim results for INSPIRE-CF: A 24-month RCT evaluating effects of weekly supervised exercise in children with CF
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept